CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

BACKGROUND: Clinical laboratory reference intervals have not been established in many African countries, and non-local intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African participants. Using laboratory reference intervals derived from other populat...

Descripció completa

Dades bibliogràfiques
Autors principals:	Karita, E, Ketter, N, Price, M, Kayitenkore, K, Kaleebu, P, Nanvubya, A, Anzala, O, Jaoko, W, Mutua, G, Ruzagira, E, Mulenga, J, Sanders, E, Mwangome, M, Allen, S, Bwanika, A, Bahemuka, U, Awuondo, K, Omosa, G, Farah, B, Amornkul, P, Birungi, J, Yates, S, Stoll-Johnson, L, Gilmour, J, Stevens, G, Shutes, E, Manigart, O, Hughes, P, Dally, L, Scott, J, Stevens, W, Fast, P, Kamali, A
Format:	Journal article
Idioma:	English
Publicat:	Public Library of Science 2009

Ítems similars

Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.
per: Price, M, et al.
Publicat: (2011)

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.
per: Stevens, W, et al.
Publicat: (2008)

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.
per: Price, M, et al.
Publicat: (2012)

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa
per: Ngongo BP, et al.
Publicat: (2012-09-01)

Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing.
per: Anzala, O, et al.
Publicat: (2008)

A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category
per: Ming M. Zhang, et al.
Publicat: (2023-09-01)

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.
per: Wallis, C, et al.
Publicat: (2010)

Time to switch from CLSI to EUCAST? a Southeast Asian perspective
per: Cusack, T, et al.
Publicat: (2019)

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
per: Cusack, T-P, et al.
Publicat: (2019)

Eﬀect of Diﬀerences in the CLSI and EUCAST Criteria on the Interpretation of Enterobacteriaceae Sensitivity to Carbapenems
per: L. A. Kornoukhova, et al.
Publicat: (2021-10-01)

Control of the HIV-1 load varies by viral subtype in a large cohort of African adults with incident HIV-1 infection
per: Price, M, et al.
Publicat: (2019)

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions.
per: Li, X, et al.
Publicat: (2014)

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions
per: Li, X, et al.
Publicat: (2014)

Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda.
per: Eugene Ruzagira, et al.
Publicat: (2011-01-01)

Evaluations of Antifungal Susceptibilities Have to Be According to Reference Guidelines: CLSI and EUCAST
per: Ali Korhan Sığ
Publicat: (2022-01-01)

Comparison of clinical antibiotic susceptibility testing interpretations to CLSI standard interpretations
per: Erin Hitchingham, et al.
Publicat: (2023-06-01)

CLSI Guided Reference Interval Limits for Cancer Biomarkers for Adults and Geriatrics
per: Richard M. Gitimu, et al.
Publicat: (2022-06-01)

Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya.
per: Nyiro, J, et al.
Publicat: (2011)

Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.
per: Tang, J, et al.
Publicat: (2011)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.
per: Amornkul, P, et al.
Publicat: (2013)

P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
per: Asiki G, et al.
Publicat: (2009-10-01)

HLA-B*57 versus HLA-B*81 in HIV-1 infection: Slow and steady wins the race?
per: Prentice, H, et al.
Publicat: (2013)

Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.
per: Prentice, H, et al.
Publicat: (2013)

Pooled Antibiotic Susceptibility Testing for Polymicrobial UTI Performs Within CLSI Validation Standards
per: Richard A. Festa, et al.
Publicat: (2025-02-01)

Novedades CLSI y EUCAST 2024 sobre detección y uso de antibióticos
per: Diego Herrera, et al.
Publicat: (2024-08-01)

Challenges, Issues and Warnings from CLSI and EUCAST Working Group on Polymyxin Susceptibility Testing
per: Yamuna Devi Bakthavatchalam, et al.
Publicat: (2017-08-01)

International health research monitoring: exploring a scientific and a cooperative approach using participatory action research.
per: Chantler, T, et al.
Publicat: (2014)

International health research monitoring: Exploring a scientific and a cooperative approach using participatory action research
per: Chantler, T, et al.
Publicat: (2014)

Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
per: Karita, E, et al.
Publicat: (2007)

Влияние расхождений критериев CLSI и EUCAST на интерпретацию чувствительности Enterobacteriaceae к карбапенемам
Publicat: (2021-10-01)

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients
per: Fast P, et al.
Publicat: (2009-10-01)

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.
per: Jaoko, W, et al.
Publicat: (2008)

Uptake of Revised CLSI Breakpoints and Potential Impact among Hospitals Reporting to The NHSN AR Option, 2022
per: Allan Nkwata, et al.
Publicat: (2024-07-01)

A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations
per: Agila Kumari Pragasam, et al.
Publicat: (2016-07-01)

Analytical measuring interval, linearity, and precision of serology assays for detection of SARS-CoV-2 antibodies according to CLSI guidelines
per: Katarzyna Haynesworth, et al.
Publicat: (2024-11-01)

Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
per: Boaz, M, et al.
Publicat: (2009)

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.
per: Mutua, G, et al.
Publicat: (2012)

CLSY docking to Pol IV requires a conserved domain critical for small RNA biogenesis and transposon silencing
per: Luisa Felgines, et al.
Publicat: (2024-11-01)

Crystal structure of 1,1,2,2-tetra-tert-butyl-1,2-dichlorodisilane,[(C4H9)2ClSi]2
per: Peters K., et al.
Publicat: (1998-04-01)

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
per: Bayingana R, et al.
Publicat: (2012-09-01)